{"id":1719,"date":"2021-05-21T20:06:56","date_gmt":"2021-05-21T20:06:56","guid":{"rendered":"https:\/\/dev7710.marketing-aide.com\/?p=1719"},"modified":"2021-09-03T13:37:55","modified_gmt":"2021-09-03T13:37:55","slug":"natco-starts-phase-iii-clinical-trial-of-molnupiravir-capsules-for-covid-19-treatment","status":"publish","type":"post","link":"https:\/\/www.natcopharma.ca\/fr\/natco-starts-phase-iii-clinical-trial-of-molnupiravir-capsules-for-covid-19-treatment\/","title":{"rendered":"NATCO lance un essai clinique de phase III sur les g\u00e9lules de Molnupiravir pour le traitement du Covid-19"},"content":{"rendered":"<a href=\"https:\/\/www.natcopharma.co.in\/about\/news\/\" target=\"_blank\" rel=\"noopener\">Lire la suite ><\/a>","protected":false},"excerpt":{"rendered":"<p>Lire la suite ><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[71],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v18.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>NATCO lance un essai clinique de phase III sur les g\u00e9lules de Molnupiravir pour le traitement du Covid-19 - Natco Pharma (Canada) Inc.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.natcopharma.ca\/fr\/natco-starts-phase-iii-clinical-trial-of-molnupiravir-capsules-for-covid-19-treatment\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"[:en]NATCO starts Phase-III Clinical Trial of Molnupiravir capsules for Covid-19 treatment[:fr]NATCO lance un essai clinique de phase III sur les g\u00e9lules de Molnupiravir pour le traitement du Covid-19[:] - Natco Pharma (Canada) Inc.\" \/>\n<meta property=\"og:description\" content=\"Lire la suite &gt;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.natcopharma.ca\/fr\/natco-starts-phase-iii-clinical-trial-of-molnupiravir-capsules-for-covid-19-treatment\/\" \/>\n<meta property=\"og:site_name\" content=\"Natco Pharma (Canada) Inc.\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-21T20:06:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-09-03T13:37:55+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"natcopharma-wpdmn\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.natcopharma.ca\/#website\",\"url\":\"https:\/\/www.natcopharma.ca\/\",\"name\":\"Natco Pharma (Canada) Inc.\",\"description\":\"Canada&#039;s High Quality Pharmaceutical Supplier\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.natcopharma.ca\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.natcopharma.ca\/fr\/natco-starts-phase-iii-clinical-trial-of-molnupiravir-capsules-for-covid-19-treatment\/#webpage\",\"url\":\"https:\/\/www.natcopharma.ca\/fr\/natco-starts-phase-iii-clinical-trial-of-molnupiravir-capsules-for-covid-19-treatment\/\",\"name\":\"[:en]NATCO starts Phase-III Clinical Trial of Molnupiravir capsules for Covid-19 treatment[:fr]NATCO lance un essai clinique de phase III sur les g\u00e9lules de Molnupiravir pour le traitement du Covid-19[:] - Natco Pharma (Canada) Inc.\",\"isPartOf\":{\"@id\":\"https:\/\/www.natcopharma.ca\/#website\"},\"datePublished\":\"2021-05-21T20:06:56+00:00\",\"dateModified\":\"2021-09-03T13:37:55+00:00\",\"author\":{\"@id\":\"https:\/\/www.natcopharma.ca\/#\/schema\/person\/016e7fee136300c5d69803a1dbba4068\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.natcopharma.ca\/fr\/natco-starts-phase-iii-clinical-trial-of-molnupiravir-capsules-for-covid-19-treatment\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.natcopharma.ca\/fr\/natco-starts-phase-iii-clinical-trial-of-molnupiravir-capsules-for-covid-19-treatment\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.natcopharma.ca\/fr\/natco-starts-phase-iii-clinical-trial-of-molnupiravir-capsules-for-covid-19-treatment\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.natcopharma.ca\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NATCO lance un essai clinique de phase III sur les g\u00e9lules de Molnupiravir pour le traitement du Covid-19\"}]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.natcopharma.ca\/#\/schema\/person\/016e7fee136300c5d69803a1dbba4068\",\"name\":\"natcopharma-wpdmn\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.natcopharma.ca\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a289f75cf550f54494a1ab2a5f9dd31e?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a289f75cf550f54494a1ab2a5f9dd31e?s=96&d=mm&r=g\",\"caption\":\"natcopharma-wpdmn\"},\"sameAs\":[\"https:\/\/dev7710.marketing-aide.com\"],\"url\":\"https:\/\/www.natcopharma.ca\/fr\/author\/natcopharma-wpdmn\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"[:en]NATCO starts Phase-III Clinical Trial of Molnupiravir capsules for Covid-19 treatment[:fr]NATCO lance un essai clinique de phase III sur les g\u00e9lules de Molnupiravir pour le traitement du Covid-19[:] - Natco Pharma (Canada) Inc.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.natcopharma.ca\/fr\/natco-starts-phase-iii-clinical-trial-of-molnupiravir-capsules-for-covid-19-treatment\/","og_locale":"fr_FR","og_type":"article","og_title":"[:en]NATCO starts Phase-III Clinical Trial of Molnupiravir capsules for Covid-19 treatment[:fr]NATCO lance un essai clinique de phase III sur les g\u00e9lules de Molnupiravir pour le traitement du Covid-19[:] - Natco Pharma (Canada) Inc.","og_description":"Lire la suite >","og_url":"https:\/\/www.natcopharma.ca\/fr\/natco-starts-phase-iii-clinical-trial-of-molnupiravir-capsules-for-covid-19-treatment\/","og_site_name":"Natco Pharma (Canada) Inc.","article_published_time":"2021-05-21T20:06:56+00:00","article_modified_time":"2021-09-03T13:37:55+00:00","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"natcopharma-wpdmn","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebSite","@id":"https:\/\/www.natcopharma.ca\/#website","url":"https:\/\/www.natcopharma.ca\/","name":"Natco Pharma (Canada) Inc.","description":"Canada&#039;s High Quality Pharmaceutical Supplier","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.natcopharma.ca\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.natcopharma.ca\/fr\/natco-starts-phase-iii-clinical-trial-of-molnupiravir-capsules-for-covid-19-treatment\/#webpage","url":"https:\/\/www.natcopharma.ca\/fr\/natco-starts-phase-iii-clinical-trial-of-molnupiravir-capsules-for-covid-19-treatment\/","name":"[:en]NATCO starts Phase-III Clinical Trial of Molnupiravir capsules for Covid-19 treatment[:fr]NATCO lance un essai clinique de phase III sur les g\u00e9lules de Molnupiravir pour le traitement du Covid-19[:] - Natco Pharma (Canada) Inc.","isPartOf":{"@id":"https:\/\/www.natcopharma.ca\/#website"},"datePublished":"2021-05-21T20:06:56+00:00","dateModified":"2021-09-03T13:37:55+00:00","author":{"@id":"https:\/\/www.natcopharma.ca\/#\/schema\/person\/016e7fee136300c5d69803a1dbba4068"},"breadcrumb":{"@id":"https:\/\/www.natcopharma.ca\/fr\/natco-starts-phase-iii-clinical-trial-of-molnupiravir-capsules-for-covid-19-treatment\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.natcopharma.ca\/fr\/natco-starts-phase-iii-clinical-trial-of-molnupiravir-capsules-for-covid-19-treatment\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.natcopharma.ca\/fr\/natco-starts-phase-iii-clinical-trial-of-molnupiravir-capsules-for-covid-19-treatment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.natcopharma.ca\/"},{"@type":"ListItem","position":2,"name":"NATCO lance un essai clinique de phase III sur les g\u00e9lules de Molnupiravir pour le traitement du Covid-19"}]},{"@type":"Person","@id":"https:\/\/www.natcopharma.ca\/#\/schema\/person\/016e7fee136300c5d69803a1dbba4068","name":"natcopharma-wpdmn","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.natcopharma.ca\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/a289f75cf550f54494a1ab2a5f9dd31e?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a289f75cf550f54494a1ab2a5f9dd31e?s=96&d=mm&r=g","caption":"natcopharma-wpdmn"},"sameAs":["https:\/\/dev7710.marketing-aide.com"],"url":"https:\/\/www.natcopharma.ca\/fr\/author\/natcopharma-wpdmn\/"}]}},"_links":{"self":[{"href":"https:\/\/www.natcopharma.ca\/fr\/wp-json\/wp\/v2\/posts\/1719"}],"collection":[{"href":"https:\/\/www.natcopharma.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.natcopharma.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.natcopharma.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.natcopharma.ca\/fr\/wp-json\/wp\/v2\/comments?post=1719"}],"version-history":[{"count":3,"href":"https:\/\/www.natcopharma.ca\/fr\/wp-json\/wp\/v2\/posts\/1719\/revisions"}],"predecessor-version":[{"id":2139,"href":"https:\/\/www.natcopharma.ca\/fr\/wp-json\/wp\/v2\/posts\/1719\/revisions\/2139"}],"wp:attachment":[{"href":"https:\/\/www.natcopharma.ca\/fr\/wp-json\/wp\/v2\/media?parent=1719"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.natcopharma.ca\/fr\/wp-json\/wp\/v2\/categories?post=1719"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.natcopharma.ca\/fr\/wp-json\/wp\/v2\/tags?post=1719"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}